Position in ELAN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,245,089
+$44,914 QoQ
Shares Held
469,916
-5.1% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $49,989,480 across 12 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
332,065 | $12,020,753 | |
| 2 | TKNO |
Alpha Teknova, Inc.
|
1,661,395 | $9,436,723 | |
| 3 | HROW |
Harrow, Inc.
|
154,587 | $6,565,309 | |
| 4 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
294,758 | $5,948,216 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
461,153 | $3,652,331 | |
| 6 | ALKS |
Alkermes plc.
|
58,072 | $3,042,972 | |
| 7 | ALVO |
Alvotech
|
558,144 | $2,059,551 | |
| 8 | SIGA |
Siga Technologies Inc
|
551,010 | $2,005,676 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,245,089 | 469,916 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,200,175 | 494,926 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $12,135,638 | 602,564 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,096,188 | 496,932 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||